Today times what new added to the portfolio $CTLT (+3 %) and

No invitation to buy and no investment advice!

WKN US1488061029

Company name Catalent Inc

https://investor.catalent.com/financial-news/default.aspx

Founded 2007 IPO 2014

Country USA

Employees 19000

Investment type medium-term - long-term

Industry Health

Dividend none

P/E ratio currently 27.45

Sales 2019 2.51 billion USD

Sales 2020 3.09 billion USD

Sales 2021 3.99 billion USD

Sales 2022 4.82 billion USD

Revenue 2023 forecast up to $4.87 billion USD (Note that reporting segments started July 1, 2022 for Q1/2023)

A global leader enabling pharmaceutical, biotechnology and consumer health partners to optimize the development, launch and delivery of better patient treatments across multiple modalities.

It recently completed a 2800sqm expansion in China in the Waigaoqiao Free Trade Zone (FTZ).

Through its flexible manufacturing platforms in over 50 locations worldwide, deliver approximately 80 billion doses of nearly 8,000+ products annually.

What do you think of $XAIR (-0,93 %) ?

Ps. Followers wanted 😊